Berglund AE - Search Results

1

BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.

Wang D, Berglund AE, Kenchappa RS, MacAulay RJ, Mulé JJ, Etame AB. Wang D, et al. Among authors: berglund ae. Sci Rep. 2017 Aug 24;7(1):9350. doi: 10.1038/s41598-017-09503-8. Sci Rep. 2017. PMID: 28839258 Free PMC article.

2

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS, Mulé JJ. Messina JL, et al. Among authors: berglund ae. Sci Rep. 2012;2:765. doi: 10.1038/srep00765. Epub 2012 Oct 24. Sci Rep. 2012. PMID: 23097687 Free PMC article.

3

BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.

Wang D, Berglund A, Kenchappa RS, Forsyth PA, Mulé JJ, Etame AB. Wang D, et al. Sci Rep. 2016 Feb 18;6:21710. doi: 10.1038/srep21710. Sci Rep. 2016. PMID: 26888114 Free PMC article.

4

Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.

Prabhakaran S, Rizk VT, Ma Z, Cheng CH, Berglund AE, Coppola D, Khalil F, Mulé JJ, Soliman HH. Prabhakaran S, et al. Among authors: berglund ae. Breast Cancer Res. 2017 Jun 19;19(1):71. doi: 10.1186/s13058-017-0864-z. Breast Cancer Res. 2017. PMID: 28629479 Free PMC article.

5

Tumour radiosensitivity is associated with immune activation in solid tumours.

Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF. Strom T, et al. Eur J Cancer. 2017 Oct;84:304-314. doi: 10.1016/j.ejca.2017.08.001. Epub 2017 Aug 29. Eur J Cancer. 2017. PMID: 28863385 Free PMC article.

6

Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production.

Konno H, Yamauchi S, Berglund A, Putney RM, Mulé JJ, Barber GN. Konno H, et al. Oncogene. 2018 Apr;37(15):2037-2051. doi: 10.1038/s41388-017-0120-0. Epub 2018 Jan 25. Oncogene. 2018. PMID: 29367762 Free PMC article.

7

Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line.

Zhu G, Nemoto S, Mailloux AW, Perez-Villarroel P, Nakagawa R, Falahat R, Berglund AE, Mulé JJ. Zhu G, et al. Among authors: berglund ae. Front Immunol. 2018 Jul 16;9:1609. doi: 10.3389/fimmu.2018.01609. eCollection 2018. Front Immunol. 2018. PMID: 30061886 Free PMC article.

8

Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma.

Wu Q, Berglund AE, Wang D, MacAulay RJ, Mulé JJ, Etame AB. Wu Q, et al. Among authors: berglund ae. Sci Rep. 2019 Oct 1;9(1):14072. doi: 10.1038/s41598-019-50489-2. Sci Rep. 2019. PMID: 31575897 Free PMC article.

9

Methylation of immune synapse genes modulates tumor immunogenicity.

Berglund A, Mills M, Putney RM, Hamaidi I, Mulé J, Kim S. Berglund A, et al. J Clin Invest. 2020 Feb 3;130(2):974-980. doi: 10.1172/JCI131234. J Clin Invest. 2020. PMID: 31714899 Free PMC article.

10

Expression of the BAD pathway is a marker of triple-negative status and poor outcome.

Boac BM, Abbasi F, Ismail-Khan R, Xiong Y, Siddique A, Park H, Han M, Saeed-Vafa D, Soliman H, Henry B, Pena MJ, McClung EC, Robertson SE, Todd SL, Lopez A, Sun W, Apuri S, Lancaster JM, Berglund AE, Magliocco AM, Marchion DC. Boac BM, et al. Among authors: berglund ae. Sci Rep. 2019 Nov 25;9(1):17496. doi: 10.1038/s41598-019-53695-0. Sci Rep. 2019. PMID: 31767884 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters